Ledger.Open graph →
SEC Form D · filed September 23, 2022

Jaguar Health, Inc

Offering
$7K
Sold
$7K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Anton Quiroz · Plano, TXDirectorMichelle D. Spreitzer · Farmington Hills, MIExecZiqiang Tang · Berkeley, CADirectorPeter Henn · Farmington Hills, MIDirectorMichael Mccormick · New York, NYDirectorJohn Micek Iii · San Francisco, CADirectorJonathan B. Siegel · San Francisco, CADirectorMichael Kramarz · New York, NYExecMorton Wendell · New York, NYDirectorJonathan Wolin · San Francisco, CAExecAnula B. Jayasuriya · San Francisco, CADirectorCraig E. Walters · Ft. Worth., TXExec · DirectorJames Bochnowski · San Francisco, CADirectorDavid Jeffrey · London, United KingdomDirectorBrian T. Stevens · Farmington Hills, MIExecCameron J. Keating · Ft. Worth., TXExecCarol Lizak · San Francisco, CAExecBlake Dube · Pittsburgh, PAExec · DirectorEgen Atkinson · New York, NYExecGilles J. De Vignemont · Summit, NJExecLisa Conte · San Francisco, CAExec · DirectorElyse E. Stock · Chapel Hill, NCDirectorSteven King · San Francisco, CAExecPeter J. Schreck · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Jaguar Health, Inc. — SEC Form D filing (2022) | Ledger